Stock Events

Stock Events

Supernus Pharmaceuticals (SUPN) Q2 2026 Earnings

5MayConfirmed

Q3 2025

Q4 2025

Q1 2026

Q2 2026

0.3

0.53

0.77

1.01

Details

Expected EPS

0.2975

Actual EPS

0.601831

Surprise EPS

0.3

Surprise Percent

+102.3%

Description

Supernus Pharmaceuticals (SUPN) has reported earnings of 0.601831 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.